AzTrials
AzTrials

TelerehabilitationNCT04259294

The Effects of a Home-based Occupational Therapy Tele-rehabilitation for Outpatients After Hip Fracture Surgery

A study testing Caspar Telerehabilitation in people with Telerehabilitation, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators will investigate the effects of a home-based occupational therapy telerehabilitation (TR) via smartphones in enhancing functional and motor performances, and fall efficacy, for outpatients receiving day hospital rehabilitation after hip fracture surgery. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Telerehabilitation
What is being tested?
Caspar Telerehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteHong Kong
Study dates
1 Jun 2018to 31 May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Primary diagnosis of hip fracture
  • Post-hip surgery within 12 weeks
  • Aged 60 years old or above
  • Medically stable
  • With Abbreviated Mental Test scored 6 or above
  • Having at least one functional limitation in the basic activities of daily living assessments

Who cannot join

  • The hip fracture is the result of malignancy
  • There is risk of falls due to postural hypotension
  • Either patients or caregiver do not understand Cantonese, English or Mandarin instructions
  • They do not use a smartphone
  • They are unable to read the instructions on the screen of the smartphone because of visual difficulty

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • The Hong Kong Polytechnic University

    Hong Kong, Hung Hom

Other trials in Hong Kong

About this study

Official title: The Effects of a Home-based Occupational Therapy Tele-rehabilitation Via Smartphones for Outpatients After Hip Fracture Surgery in Hong Kong: A Feasibility Randomized Controlled Study

The investigators will investigate the effects of a home-based occupational therapy telerehabilitation (TR) via smartphones in enhancing functional and motor performances, and fall efficacy, for outpatients receiving day hospital rehabilitation after hip fracture surgery.

This is a feasibility randomized controlled trial with two groups - experimental and comparison groups, involving older adults after hip fracture surgery within 12 weeks attending the Geriatric Day Hospital. Patients will be assessed at baseline, immediately post 3-weeks intervention, and follow-up after 3-weeks for motor performances, daily activities functioning and fall efficacy. The experimental group will receive home program using the use of Caspar Health e-system and a mobile app in smartphones, while the comparison group will receive paper-and-pencil instructions for the home program on weekly basis, for 3 weeks.

Being tested
Caspar Telerehabilitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Caspar TelerehabilitationBehavioural

    The experimental group will receive home-based treatment program through mobile apps while control group will receive through a written home program sheets. The training contents will be equivalent, including trunk and lower limb strengthening and stretching, coordination, balance, and functional exercises that will be related to patients' daily living activities in their home.

    The frequency and duration of the home program will be compromised by both the therapist and the patient. The videos of the home program will be sent to patients' app in smartphone by the therapist in the experimental group. Patients will perform the exercises while watching the videos in the app. After each exercise will be done, patient's performance feedback will be captured by the smartphone and will be sent back to the case therapist each time through the app while those in the control group will record their performance in a log sheet given by the therapists.

Study groups in NCT04259294
Study groupRoleWhat they receive
Telerehabilitation group via mobile appsExperimentalThe experimental group will receive home-based treatment program through mobile apps
Receives: Behavioral: Caspar Telerehabilitation
Control group via paper and pencil instructionsActive comparatorThe control group will receive treatment via written home program sheets
Receives: Behavioral: Caspar Telerehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timed up and go test (TUG)

    It measures fall risk and progress in walking speed (Change from baseline at post 3-week intervention and follow-up after 3 weeks)

    Measured: Measure assessing change between three time points (baseline, post 3-week intervention and follow-up after 3 weeks)

  2. The Functional Reach Test (FR)

    It measures balance (Change from baseline at post 3-week intervention and follow-up after 3 weeks)

    Measured: Measure assessing change between three time points (baseline, post 3-week intervention and follow-up after 3 weeks)

  3. Muscle strength (MS)

    It will be measured using a force gauge on the strength of Quadriceps of both the affected and the non-affected legs (Change from baseline at post 3-week intervention and follow-up after 3 weeks)

    Measured: Measure assessing change between three time points (baseline, post 3-week intervention and follow-up after 3 weeks)

  4. The Pain Visual Analogue Scale (VAS)

    It measures pain intensity. It consists of a 100mm horizontal line anchored with two opposite labels, i.e. labelled at the left end as 'no pain' (0mm) and at the right end as 'very severe pain' (100mm). (Change from baseline at post 3-week intervention and follow-up after 3 weeks)

    Measured: Measure assessing change between three time points (baseline, post 3-week intervention and follow-up after 3 weeks)

Secondary outcomes (4)
  1. The Hong Kong Chinese version of the Modified Barthel index (MBI)

    It measures performance in basic activities of daily living. The item scores range from '0', which indicates an inability to perform, to a maximum of '5, 10 or 15', which represents total independence. The total items score of 100 indicates complete independence in self-care performance. (Change from baseline at post 3-week intervention and follow-up after 3 weeks)

    Measured: Measure assessing change between three time points (baseline, post 3-week intervention and follow-up after 3 weeks)

  2. The Hong Kong Chinese version of the Lawton Instrumental Activities of Daily Living (IADL)

    It assesses nine domains of function skills (ability to use telephone, shopping, meal preparation, laundry, housekeeping, handyman work, and transportation, medication and money management) The item scores range from '0' which indicates an inability to perform, to a maximum of '2,3 or 4' which represents total independence (Change from baseline at post 3-week intervention and follow-up after 3 weeks)

    Measured: Measure assessing change between three time points (baseline, post 3-week intervention and follow-up after 3 weeks)

  3. The Fall Efficacy Scale (FES)

    FES is a questionnaire to assess the level of confidence when patient perform activities of daily living without fear of fall. FES is a ten-item test rated on a 10-point scale from not confident at all to completely confident (Change from baseline at post 3-week intervention and follow-up after 3 weeks)

    Measured: Measure assessing change between three time points (baseline, post 3-week intervention and follow-up after 3 weeks)

  4. The Morse Fall Scale (MFS)

    MFS predict the likelihood of falls. It consists of 6 variables: history of fall, the presence of a secondary diagnosis, the use of ambulatory aids, the administration of intravenous therapy, types of gait and mental status. MFS is rated as follows, 0: No risk for falls; <25: Low risk; 25-45: Moderate risk ; >45: High risk (Change from baseline at post 3-week intervention and follow-up after 3 weeks)

    Measured: Measure assessing change between three time points (baseline, post 3-week intervention and follow-up after 3 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2020
  2. Study start1 Jun 2018
  3. Primary completion31 May 2019
  4. Study completion31 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04259294
Sponsor's protocol ID
HongKongPOLYU
Status last verified
Feb 2020
First submitted
9 Jan 2020
Last updated
6 Feb 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Caspar Telerehabilitation in people with Telerehabilitation, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timed up and go test (TUG) (time frame: Measure assessing change between three time points (baseline, post 3-week intervention and follow-up after 3 weeks)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in